Cargando…

Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker

BACKGROUND: The molecular pathogenesis of T-cell large granular lymphocytic leukemia (T-LGLL), a mature T-cell leukemia arising commonly from T-cell receptor αβ-positive CD8(+) memory cytotoxic T cells, is only partly understood. The role of deregulated methylation in T-LGLL is not well known. We an...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, Patricia, Laguna, Teresa, Ossowski, Julio, Pancaldi, Vera, Brauser, Martina, Dührsen, Ulrich, Keuneke, Lara, Queiros, Ana, Richter, Julia, Martín-Subero, José I., Siebert, Reiner, Schlegelberger, Brigitte, Küppers, Ralf, Dürig, Jan, Murga Penas, Eva M., Carillo-de Santa Pau, Enrique, Bergmann, Anke K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664638/
https://www.ncbi.nlm.nih.gov/pubmed/36376973
http://dx.doi.org/10.1186/s13148-022-01362-z
_version_ 1784831142448332800
author Johansson, Patricia
Laguna, Teresa
Ossowski, Julio
Pancaldi, Vera
Brauser, Martina
Dührsen, Ulrich
Keuneke, Lara
Queiros, Ana
Richter, Julia
Martín-Subero, José I.
Siebert, Reiner
Schlegelberger, Brigitte
Küppers, Ralf
Dürig, Jan
Murga Penas, Eva M.
Carillo-de Santa Pau, Enrique
Bergmann, Anke K.
author_facet Johansson, Patricia
Laguna, Teresa
Ossowski, Julio
Pancaldi, Vera
Brauser, Martina
Dührsen, Ulrich
Keuneke, Lara
Queiros, Ana
Richter, Julia
Martín-Subero, José I.
Siebert, Reiner
Schlegelberger, Brigitte
Küppers, Ralf
Dürig, Jan
Murga Penas, Eva M.
Carillo-de Santa Pau, Enrique
Bergmann, Anke K.
author_sort Johansson, Patricia
collection PubMed
description BACKGROUND: The molecular pathogenesis of T-cell large granular lymphocytic leukemia (T-LGLL), a mature T-cell leukemia arising commonly from T-cell receptor αβ-positive CD8(+) memory cytotoxic T cells, is only partly understood. The role of deregulated methylation in T-LGLL is not well known. We analyzed the epigenetic profile of T-LGLL cells of 11 patients compared to their normal counterparts by array-based DNA methylation profiling. For identification of molecular events driving the pathogenesis of T-LGLL, we compared the differentially methylated loci between the T-LGLL cases and normal T cells with chromatin segmentation data of benign T cells from the BLUEPRINT project. Moreover, we analyzed gene expression data of T-LGLL and benign T cells and validated the results by pyrosequencing in an extended cohort of 17 patients, including five patients with sequential samples. RESULTS: We identified dysregulation of DNA methylation associated with altered gene expression in T-LGLL. Since T-LGLL is a rare disease, the samples size is low. But as confirmed for each sample, hypermethylation of T-LGLL cells at various CpG sites located at enhancer regions is a hallmark of this disease. The interaction of BLC11B and C14orf64 as suggested by in silico data analysis could provide a novel pathogenetic mechanism that needs further experimental investigation. CONCLUSIONS: DNA methylation is altered in T-LGLL cells compared to benign T cells. In particular, BCL11B is highly significant differentially methylated in T-LGLL cells. Although our results have to be validated in a larger patient cohort, BCL11B could be considered as a potential biomarker for this leukemia. In addition, altered gene expression and hypermethylation of enhancer regions could serve as potential mechanisms for treatment of this disease. Gene interactions of dysregulated genes, like BLC11B and C14orf64, may play an important role in pathogenic mechanisms and should be further analyzed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-022-01362-z.
format Online
Article
Text
id pubmed-9664638
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96646382022-11-15 Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker Johansson, Patricia Laguna, Teresa Ossowski, Julio Pancaldi, Vera Brauser, Martina Dührsen, Ulrich Keuneke, Lara Queiros, Ana Richter, Julia Martín-Subero, José I. Siebert, Reiner Schlegelberger, Brigitte Küppers, Ralf Dürig, Jan Murga Penas, Eva M. Carillo-de Santa Pau, Enrique Bergmann, Anke K. Clin Epigenetics Research BACKGROUND: The molecular pathogenesis of T-cell large granular lymphocytic leukemia (T-LGLL), a mature T-cell leukemia arising commonly from T-cell receptor αβ-positive CD8(+) memory cytotoxic T cells, is only partly understood. The role of deregulated methylation in T-LGLL is not well known. We analyzed the epigenetic profile of T-LGLL cells of 11 patients compared to their normal counterparts by array-based DNA methylation profiling. For identification of molecular events driving the pathogenesis of T-LGLL, we compared the differentially methylated loci between the T-LGLL cases and normal T cells with chromatin segmentation data of benign T cells from the BLUEPRINT project. Moreover, we analyzed gene expression data of T-LGLL and benign T cells and validated the results by pyrosequencing in an extended cohort of 17 patients, including five patients with sequential samples. RESULTS: We identified dysregulation of DNA methylation associated with altered gene expression in T-LGLL. Since T-LGLL is a rare disease, the samples size is low. But as confirmed for each sample, hypermethylation of T-LGLL cells at various CpG sites located at enhancer regions is a hallmark of this disease. The interaction of BLC11B and C14orf64 as suggested by in silico data analysis could provide a novel pathogenetic mechanism that needs further experimental investigation. CONCLUSIONS: DNA methylation is altered in T-LGLL cells compared to benign T cells. In particular, BCL11B is highly significant differentially methylated in T-LGLL cells. Although our results have to be validated in a larger patient cohort, BCL11B could be considered as a potential biomarker for this leukemia. In addition, altered gene expression and hypermethylation of enhancer regions could serve as potential mechanisms for treatment of this disease. Gene interactions of dysregulated genes, like BLC11B and C14orf64, may play an important role in pathogenic mechanisms and should be further analyzed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13148-022-01362-z. BioMed Central 2022-11-14 /pmc/articles/PMC9664638/ /pubmed/36376973 http://dx.doi.org/10.1186/s13148-022-01362-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Johansson, Patricia
Laguna, Teresa
Ossowski, Julio
Pancaldi, Vera
Brauser, Martina
Dührsen, Ulrich
Keuneke, Lara
Queiros, Ana
Richter, Julia
Martín-Subero, José I.
Siebert, Reiner
Schlegelberger, Brigitte
Küppers, Ralf
Dürig, Jan
Murga Penas, Eva M.
Carillo-de Santa Pau, Enrique
Bergmann, Anke K.
Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
title Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
title_full Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
title_fullStr Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
title_full_unstemmed Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
title_short Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker
title_sort epigenome-wide analysis of t-cell large granular lymphocytic leukemia identifies bcl11b as a potential biomarker
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664638/
https://www.ncbi.nlm.nih.gov/pubmed/36376973
http://dx.doi.org/10.1186/s13148-022-01362-z
work_keys_str_mv AT johanssonpatricia epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT lagunateresa epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT ossowskijulio epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT pancaldivera epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT brausermartina epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT duhrsenulrich epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT keunekelara epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT queirosana epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT richterjulia epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT martinsuberojosei epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT siebertreiner epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT schlegelbergerbrigitte epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT kuppersralf epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT durigjan epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT murgapenasevam epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT carillodesantapauenrique epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker
AT bergmannankek epigenomewideanalysisoftcelllargegranularlymphocyticleukemiaidentifiesbcl11basapotentialbiomarker